Since COVID-19, the public awareness of antibodies and their key role in our collective fight against corona is constantly growing. This article will shed light on how antibodies benefit us in times of COVID-19.
As is the case with a growing number of industries, the medical and pharmaceutical fields are increasingly turning to working with third-party providers. Manufacturers of antibody therapeutics are outsourcing certain process steps to contract manufacturers for various reasons, be it to cut costs or to speed up production.
Antibody development and antibody expression have become essential in life-science and the biopharmaceutical industry. In particular, advanced methods of creating and selecting recombinant antibodies have enabled science and medicine alike to progress in unanticipated speed.